Citation only
via OpenAlex
FP115KIDNEY BIOPSY IN THE ELDERLY: FRAILTY INDEX IS A GOOD TOOL TO PREDICT CLINICAL OUTCOMES
Vittorio Di Maso, Elisabetta Ermacora, Michele Carraro, Katiuscia Scala, Giuliano Boscutti
Nephrology Dialysis Transplantation · 2018
Abstract
INTRODUCTION AND AIMS: Kidney biopsy is the golden standard for renal disease diagnosis and treatment. Nevertheless, in older subjects risk and clinical outcomes are dependent from a combination of biological, functional, psychological, and environmental factors. Tools that effectively identify patients with different life expectancies should be multidimensional. A Multidimensional Prognostic Index (MPI) for 1-year mortality derived from a standardized Comprehensive Geriatric Assessment (CGA) was developed for this purpose. No data are available regarding the association between frailty index and clinical outcomes in elderly subjects undergoing kidney biopsy. Aim of this study was to evaluate the usefulness of MPI for predicting mortality, treatment failure and requirement of chronic dialysis in elderly patients after renal biopsy. METHODS: Biopsy and clinical data from 67 patients aged ≥65 years were retrospectively collected revising renal biopsies performed in our department from January 2015 to June 2017. Follow-up period was at least 6 months. Patients were stratified at the time of renal biopsy according to both age (65-74 years; ≥75 years) and MPI (low-frailty: MPI-1; medium-frailty: MPI-2; high-frailty: MPI-3). Clinical outcomes were death from any cause, response to therapy, need of chronic RRT, biopsy-related complications and therapy-related complications. Data are reported as mean±SD and t-test or ANOVA have been used to compare groups. RESULTS: Cohort consisted of 67 patients, 30 women (44.8%) and 37 men (55.2%), mean age was 75±6,2 years. Neither biopsy-related complications nor therapy-related complications were observed in the cohort studied. Death was more frequent in older patients ranging from low-frailty to high-frailty patients ( with MPI-1 (MPI 1=8.8 %, MPI 2=25.9%), being 100% in patients with MPI 3 (p<0.05). The frequency of treatment failure was similar in the two age groups (41.9% in 65-74 years vs 44.4% in over 75), but it increased according to frailty grading (MPI-1=44,1%, MPI-2=63%, MPI-3=100%; p<0,05). According to the age stratification, no differences were observed in the percentage of patients requiring chronic dialysis; by contrast, patients with higher MPI showed higher probability to continue dialytic treatment (MPI-1=14.7%, MPI-2= 44.4%, MPI-3=66.7%; p<0,05). Data are summarized in Figure1. CONCLUSIONS: Kidney biopsy and related treatment are safe in the elderly. Clinical outcomes are not depending on age at the biopsy, while frailty index might better identify patients with worst outcome in terms of treatment failure and need of chronic dialysis. In conclusion, MPI could be considered a useful tool to identify patients at higher risk helping clinicians in evaluating risks and benefits of the diagnostic procedure.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ndt/gfy104.fp115
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Maso, V.D., Ermacora, E., Carraro, M., Scala, K., & Boscutti, G. (2018). FP115KIDNEY BIOPSY IN THE ELDERLY: FRAILTY INDEX IS A GOOD TOOL TO PREDICT CLINICAL OUTCOMES. <em>Nephrology Dialysis Transplantation</em>. https://doi.org/10.1093/ndt/gfy104.fp115
Vancouver
Maso VD, Ermacora E, Carraro M, Scala K, Boscutti G. FP115KIDNEY BIOPSY IN THE ELDERLY: FRAILTY INDEX IS A GOOD TOOL TO PREDICT CLINICAL OUTCOMES. Nephrology Dialysis Transplantation. 2018. doi:10.1093/ndt/gfy104.fp115.
BibTeX
@article{vittorio2018FPKIDN,
title = {FP115KIDNEY BIOPSY IN THE ELDERLY: FRAILTY INDEX IS A GOOD TOOL TO PREDICT CLINICAL OUTCOMES},
author = {Vittorio Di Maso and Elisabetta Ermacora and Michele Carraro and Katiuscia Scala and Giuliano Boscutti},
journal = {Nephrology Dialysis Transplantation},
year = {2018},
doi = {10.1093/ndt/gfy104.fp115},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Age and Ageing 2021
Open access · CC-BY
Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study
University of Lorraine 2022
Open access · US-GOV
Prevalence and Comorbidities of Dermatoporosis: a French Prospective Observational Study in General Medicine Consultation
University of Limerick 2026
Open access · US-GOV
A Prospective Cohort Study to Assess Frailty, Healthcare Needs and Health Related Quality of Life in Patients With a Diagnosis of Prostate Cancer
BMC Cancer 2018
Open access · CC-BY
Validation of a frailty index in older cancer patients with solid tumours
BMC Geriatrics 2002
Open access · OA
Frailty, fitness and late-life mortality in relation to chronological and biological age
Clinical Interventions in Aging 2017
Open access · CC-BY